ArticleCancer research communications2026
OB-001 Enhances Osimertinib Brain Penetration: Preclinical Pharmacokinetics and Translational Rationale for EGFR-Mutant NSCLC with CNS Disease.
Hitesh B Mistry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.